Literature DB >> 22025884

Severe chronic diarrhea and maculopapular rash: a case report.

Alessandra Elvevi1, Federica Grifoni, Federica Branchi, Umberto Gianelli, Dario Conte.   

Abstract

Systemic mastocytosis (SM) is a heterogeneous disease of the bone marrow characterized by abnormal growth, accumulation and activation of clonal mast cells (MCs). We report a case of SM with multi-organ involvement. A 30-year-old man presented with diarrhea, flushing, maculopapular rash with itching and weight loss. The upper and lower gastrointestinal endoscopies showed macroscopic involvement of stomach and duodenum; mucosal samples from stomach, duodenum, colon and distal ileum showed mucosal infiltration by large, spindle-shaped MCs with abnormal surface molecule expression (CD2 and CD25), a picture fully consistent with SM, according to the World Health Organization diagnostic criteria. A computed tomography scan showed diffuse lymphadenopathy, hepatosplenomegaly and diffuse small bowel involvement. Bone marrow aspirate and biopsy were diagnostic for SM; serum tryptase levels were increased (209 ng/mL, normal values < 20 ng/mL). The conclusive diagnosis was smouldering SM. There were no therapeutic indications except for treatment of symptoms. The patient was strictly followed up because of the risk of aggressive evolution.

Entities:  

Keywords:  Bone marrow; Mast cells; Systemic mastocytosis; Tryptase

Mesh:

Year:  2011        PMID: 22025884      PMCID: PMC3198025          DOI: 10.3748/wjg.v17.i34.3948

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

1.  Treatment of systemic mast-cell disease with cladribine.

Authors:  A Tefferi; C Y Li; J H Butterfield; H C Hoagland
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

Review 2.  Diagnosis and treatment of systemic mastocytosis: state of the art.

Authors:  Peter Valent; Cem Akin; Wolfgang R Sperr; Hans-P Horny; Michel Arock; Klaus Lechner; John M Bennett; Dean D Metcalfe
Journal:  Br J Haematol       Date:  2003-09       Impact factor: 6.998

3.  CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens.

Authors:  Karl Sotlar; Hans-Peter Horny; Ingrid Simonitsch; Manuela Krokowski; Karl J Aichberger; Matthias Mayerhofer; Dieter Printz; Gerhard Fritsch; Peter Valent
Journal:  Am J Surg Pathol       Date:  2004-10       Impact factor: 6.394

Review 4.  Histopathological and immunohistochemical aspects of mastocytosis.

Authors:  Hans-Peter Horny; Peter Valent
Journal:  Int Arch Allergy Immunol       Date:  2002-02       Impact factor: 2.749

5.  Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase.

Authors:  Knut Brockow; Cem Akin; Mary Huber; Linda M Scott; Lawrence B Schwartz; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2002-01       Impact factor: 10.793

Review 6.  Mastocytosis: pathology, genetics, and current options for therapy.

Authors:  Peter Valent; Cem Akin; Wolfgang R Sperr; Matthias Mayerhofer; Manuela Födinger; Robert Fritsche-Polanz; Karl Sotlar; Luis Escribano; Michel Arock; Hans-Peter Horny; Dean D Metcalfe
Journal:  Leuk Lymphoma       Date:  2005-01

7.  Cladribine therapy for systemic mastocytosis.

Authors:  Hanneke C Kluin-Nelemans; J Marja Oldhoff; Jasper J Van Doormaal; Jan W Van 't Wout; Gregor Verhoef; Wim B J Gerrits; O Aart van Dobbenburgh; Suzanne G Pasmans; Rob Fijnheer
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

8.  Imatinib for systemic mast-cell disease.

Authors:  A Pardanani; M Elliott; T Reeder; C Y Li; E J Baxter; N C P Cross; A Tefferi
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

Review 9.  Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.

Authors:  Animesh Pardanani; Ayalew Tefferi
Journal:  Curr Opin Hematol       Date:  2010-03       Impact factor: 3.284

10.  Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.

Authors:  H-P Horny; K Sotlar; W R Sperr; P Valent
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  1 in total

1.  Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma.

Authors:  Philipp Tschandl; Leonhard Müllauer; Harald Kittler
Journal:  Dermatol Pract Concept       Date:  2012-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.